Maxposure Limited IPO

The Maxposure Limited IPO, a significant book-built issue valued at Rs. 20.26 crores. This fresh issue comprises 61.4 lakh shares, marking a promising opportunity for those seeking a strategic investment.

Scheduled to open on January 15, 2024, the Maxposure IPO subscription window closes on January 17, 2024. The anticipated allotment date is set for Thursday, January 18, 2024. The listing on NSE SME is slated for Monday, January 22, 2024, creating a buzz in the market.

Priced competitively at Rs. 31 to Rs. 33 per share, Maxposure IPO beckons investors with a minimum lot size of 4000 shares. Retail investors can enter the game with a minimum investment of Rs. 132,000, while High Net Worth Individuals (HNI) need a minimum investment of Rs. 264,000 for 2 lots (8,000 shares).

Driving this IPO is GYR Capital Advisors Private Limited, a trusted book running lead manager, with Bigshare Services Pvt Ltd handling the registration process. Giriraj Stock Broking assumes the crucial role of the market maker for Maxposure IPO.

For detailed insights, investors are urged to refer to the Maxposure IPO Red Herring Prospectus (RHP), offering comprehensive information on this enticing investment opportunity. In the dynamic landscape of IPOs, Maxposure Limited emerges as a beacon of potential returns for astute investors.

Maxposure IPO Details

Maxposure Limited is set to make waves in the market with its upcoming IPO, offering investors a golden opportunity from January 15 to January 17, 2024.

With a face value of Rs. 10 per share, Maxposure’s IPO is priced competitively between Rs. 31 to Rs. 33 per share, catering to a diverse investor base. The lot size stands at 4000 shares, making it accessible for a wide range of investors, while the total issue size is an impressive 6,140,000 shares, aggregating up to Rs. 20.26 Cr.

This IPO falls under the category of a Book Built Issue, emphasizing its dynamic nature and investor-driven pricing. Maxposure’s listing will take place on the esteemed NSE SME platform, adding an extra layer of credibility.

The pre-issue shareholding is noted at 16,600,950, and post-issue, it is expected to rise to 22,740,950, reflecting the company’s growth trajectory. An interesting facet of the IPO is the Market Maker portion, set at 372,000 shares, indicating a strategic partnership with Giriraj Stock Broking.

Investors eyeing Maxposure Limited IPO are encouraged to delve into the intricacies of the offering, considering the compelling figures and the potential it holds for market enthusiasts. As the IPO landscape continues to evolve, Maxposure stands as a beacon for those seeking strategic investment opportunities.

IPO Date	January 15, 2024 to January 17, 2024
Face Value	₹10 per share
Price Band	₹31 to ₹33 per share
Lot Size	4000 Shares
Total Issue Size	6,140,000 shares (aggregating up to ₹20.26 Cr)
Fresh Issue	6,140,000 shares (aggregating up to ₹20.26 Cr)
Issue Type	Book Built Issue IPO
Listing At	NSE SME
Share holding pre issue	16,600,950
Share holding post issue	22,740,950
Market Maker portion	372,000 shares

Maxposure IPO Reservation

The upcoming Maxposure IPO has created a buzz in the financial market, offering a promising investment opportunity. To ensure a seamless participation process, potential investors should be well-versed in the IPO reservation structure.

Investors will find three distinct categories in the Maxposure IPO reservation: Qualified Institutional Buyers (QIB), Retail, and Non-Institutional Investors (NII or HNI). The allocation of shares is strategically divided, catering to diverse investor preferences.

Qualified Institutional Buyers (QIB): QIBs are allocated a maximum of 50% of the Net Issue. For institutional investors seeking substantial shares, this category provides an attractive proposition.

Retail Investors: With no less than 35% of the Net Issue reserved for retail investors, this segment caters to individual investors looking for a balanced and accessible investment opportunity.

Non-Institutional Investors (NII or HNI): High Net Worth Individuals (HNIs) can look forward to a reserved offering of no less than 15% of the Net Issue. This category appeals to investors seeking a more significant stake in the IPO.

Investor Category	Shares Offered
QIB Shares Offered	Not more than 50% of the Net Issue
Retail Shares Offered	Not less than 35% of the Net Issue
NII (HNI) Shares Offered	Not less than 15% of the Net Issue

Maxposure IPO Comprehensive Timeline

IPO Opening and Closing Dates: The Maxposure IPO opens its subscription window on Monday, January 15, 2024, presenting investors with a limited timeframe until Wednesday, January 17, 2024, to submit their applications.

UPI Mandate Confirmation Cut-off: A critical milestone is the cut-off time for UPI mandate confirmation, set at 5 PM on January 17, 2024. Investors must confirm their UPI mandates by this deadline to ensure a smooth transaction process.

Basis of Allotment: On Thursday, January 18, 2024, the Basis of Allotment is revealed, shedding light on the allocation of shares across various investor categories.

Refunds and Share Credit: January 19, 2024, marks the initiation of refunds for unsuccessful applicants. Simultaneously, successful applicants witness the credit of shares to their Demat accounts on the same day.

Listing Date: The culmination of this IPO journey arrives on Monday, January 22, 2024, as Maxposure makes its debut on the stock market.

Date	Event
January 15, 2024	Maxposure IPO Opens
January 17, 2024 (5 PM)	UPI Mandate Confirmation Cut-off
January 17, 2024	Maxposure IPO Closes
January 18, 2024	Basis of Allotment Disclosure
January 19, 2024	Refunds Initiation and Share Credit
January 22, 2024	Maxposure IPO Listing Date

Maxposure IPO Lot Size

Investors eyeing the Maxposure IPO must strategically navigate the lot size dynamics, understanding the minimum and maximum bidding requirements. This information is crucial for optimizing investment decisions and aligning portfolios with individual financial goals.

Retail Investors: Retail investors can bid for a minimum of 1 lot, equivalent to 4000 shares, requiring an investment of Rs. 132,000. This provides a low-entry point, allowing small-scale investors to participate actively in the IPO.

The maximum bidding capacity for retail investors remains at 1 lot, translating to 4000 shares, with a corresponding investment cap of Rs. 132,000. This structure ensures inclusivity and accommodates a diverse range of retail investors.

HNI Investors: High Net Worth Individuals (HNIs) have a higher bidding threshold, with a minimum requirement of 2 lots, totaling 8000 shares. This necessitates a minimum investment of Rs. 264,000, providing a more substantial stake in the IPO.

The maximum investment capacity for HNI investors aligns with the minimum, set at 2 lots or 8000 shares, requiring a maximum investment of Rs. 264,000. This allows HNIs flexibility in scaling their investment without compromising diversity.

Application	Lots	Shares	Amount
Retail (Min)	1	4000	₹132,000
Retail (Max)	1	4000	₹132,000
HNI (Min)	2	8,000	₹264,000

Maxposure IPO Promoter Holding

A critical aspect to consider is the promoter holding structure, shedding light on the ownership dynamics before and after the issue.

Pre-Issue Promoter Holding: Before the IPO, Prakash Johari and Sweta Johari, the promoters of Maxposure, collectively hold a substantial 84.35% stake in the company. This high pre-issue ownership signifies a strong alignment of the promoters with the business, showcasing their confidence in its growth potential.

Post-Issue Promoter Holding: Post the IPO, the promoter holding undergoes a shift, reducing to 61.58%. This change is a result of the issuance of new shares to public investors. While the decrease in percentage is expected, the promoters’ retained majority stake signifies an ongoing commitment and belief in the company’s prosperity.

Share Holding Pre Issue	84.35%
Share Holding Post Issue	61.58%

Maxposure IPO Grey Market Premium (GMP)

Investors eyeing the Maxposure SME IPO are closely monitoring the Grey Market Premium (GMP) as a key indicator of market sentiment and potential listing performance. The latest GMP, reported at Rs. 40 as of January 12th, 2024, 01:35 PM, signifies a robust demand in the secondary market.

With the IPO’s price band set at Rs. 33.00, the estimated listing price, considering the cap price and today’s GMP, is projected at Rs. 73. This reflects a substantial expected percentage gain/loss per share of 121.21%, providing investors with valuable insights into potential returns.

It’s noteworthy that the Retail Subject to Sauda is set at Rs. 121,600, showcasing a considerable interest among retail investors. The daily GMP trend over the last four sessions indicates positive market activity, with the lowest GMP recorded at Rs. 5 and the highest at Rs. 40. This suggests a dynamic and upward trajectory, anticipating a strong listing for Maxposure SME IPO.

Investors are advised to stay informed and follow daily updates on Maxposure SME IPO GMP for an accurate gauge of market expectations. The shifting GMP points towards an optimistic outlook, making it imperative for investors to stay abreast of the daily trends as they navigate the exciting journey towards the IPO listing.

Maxposure Day-wise IPO GMP Trend

GMP Date	IPO Price	GMP	Sub2 Sauda Rate	Estimated Listing Price	Last Updated
12-01-2024	33.00	₹40 Up	121600	₹73 (121.21%)	12-Jan-2024 13:35
11-01-2024	33.00	₹36 No change	109400	₹69 (109.09%)	11-Jan-2024 23:24
10-01-2024	33.00	₹36 Up	109400	₹69 (109.09%)	10-Jan-2024 23:32
09-01-2024	33.00	₹5 No change	15200	₹38 (15.15%)	9-Jan-2024 23:23

Key Performance Indicator

The Key Performance Indicators (KPIs) provides a comprehensive understanding of the company’s financial health and performance. Here’s a breakdown of the essential KPIs that shed light on Maxposure’s standing in the market:

Return on Equity (ROE): Maxposure IPO boasts a commendable ROE of 14.39%, reflecting its ability to generate profits from shareholders’ equity.

Return on Capital Employed (ROCE): With an ROCE of 19.55%, Maxposure demonstrates efficient utilization of capital for productive operations, contributing to overall profitability.

Debt/Equity Ratio: The Debt/Equity ratio of 0.03 indicates a conservative approach to financing, signifying low reliance on external borrowings and a healthy financial structure.

Return on Net Worth (RoNW): Maxposure maintains a robust RoNW of 14.20%, showcasing its ability to generate returns from the net worth of the business.

Price-to-Book Value (P/BV): The P/BV ratio, standing at 1.59, signifies a balanced market valuation relative to the book value, providing investors insights into the company’s market perception.

Investors can use these KPIs to gauge Maxposure’s financial stability, operational efficiency, and market positioning. The market capitalization of Rs 75.05 Cr further underlines the company’s size and potential for growth. As investors navigate the IPO landscape, a thorough analysis of these KPIs equips them with valuable insights to make informed investment decisions aligned with their financial objectives.

KPI	Values
ROE	14.39%
ROCE	19.55%
Debt/Equity	0.03
RoNW	14.20%
P/BV	1.59

Maxposure Limited Transforming Media and Entertainment Landscape

Founded on August 17, 2006, Maxposure Limited has emerged as a leading provider of personalized media and entertainment services, showcasing expertise in Inflight Entertainment, Content Marketing, Technology, and Advertising. Headquartered in Mumbai, the company’s state-of-the-art lab facility offers a spectrum of services, including custom editing, metadata creation, duplication, audio enhancement, and encoding/transcoding for various platforms.

Diverse Service Offerings: Maxposure’s services are meticulously organized into four main categories: Inflight Entertainment, Content Marketing, Technology, and Advertising. This strategic segmentation allows the company to cater to a broad spectrum of client needs, ensuring a comprehensive approach to media solutions.

Global Reach and Project Success: With a robust sales network spanning Delhi, Mumbai, Bengaluru, and Kolkata, Maxposure has positioned itself as a key player in the Indian market. Beyond domestic borders, the company has successfully undertaken and managed projects in the Indian subcontinent and the Middle East, collaborating with esteemed clients like Gulf Air, Air Arabia, VFS, and Jazeera Airways.

Financial Performance: Maxposure’s financial performance underscores its growth trajectory. The company reported revenues of Rs. 1726.28 lakhs during the three months ending September 30, 2023. In the fiscal years 2023, 2022, and 2021, domestic operations yielded revenues of Rs. 2835.08 lakhs, Rs. 2815.85 lakhs, and Rs. 1940.76 lakhs, respectively. International operations contributed revenues of Rs. 289.86 lakhs, Rs. 343.84 lakhs, Rs. 452.15 lakhs, and Rs. 75.09 lakhs during the same periods.

Workforce and Vision: As of October 31, 2023, Maxposure Limited boasts a dedicated team of 81 employees. This talented workforce plays a pivotal role in realizing the company’s vision of delivering cutting-edge media and entertainment services to a global audience.

Maxposure Limited stands poised at the intersection of innovation and industry prowess, embodying a commitment to excellence in the dynamic landscape of media and entertainment services.

Maxposure Limited Financial Restatement A Strategic Surge in Performance

Maxposure Limited’s financial landscape has witnessed a notable transformation, as reflected in the restated financial information for the periods ending on March 31, 2023, and March 31, 2022. The company’s robust performance is evident in key metrics, showcasing a strategic surge in revenue and profit after tax (PAT).

Revenue Growth: Maxposure’s revenue increased by 1.03% between March 31, 2023, and March 31, 2022. This positive trajectory signifies the company’s resilience and adaptability in a dynamic market environment.

Profit After Tax (PAT): The profit after tax witnessed a remarkable upswing of 1162.04% during the same period. This substantial growth underscores Maxposure’s effective operational strategies and financial management.

Period Ended	Assets	Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
30 Sep 2023	5,355.21	2,059.05	370.83	3,478.21	3,146.19	462.31
31 Mar 2023	4,878.51	3,355.55	441.21	3,114.34	2,775.36	333.76
31 Mar 2022	4,485.18	3,321.31	34.96	2,666.17	2,334.15	293.65
31 Mar 2021	4,009.97	2,247.27	36.22	2,631.21	2,299.19	418.52

Maxposure IPO Objectives Strategic Utilization of Net Proceeds

As Maxposure Limited gears up for its IPO, a transparent outline of the intended utilization of Net Proceeds provides investors with insights into the company’s strategic priorities. The proceeds from the Issue are earmarked for the following key objectives:

Certification Acquisition for Innovative Products: A significant portion of the Net Proceeds will be allocated towards obtaining certifications from the Federal Aviation Administration (FAA) and the European Union Aviation Safety Agency (EASA) for the Wireless Streaming Server (“AeroHub”) and the Patented Inviseo tray table. These cutting-edge products collectively referred to as the “Proposed Products,” showcase the company’s commitment to innovation and excellence.

Working Capital Requirements: A portion of the funds raised will be dedicated to meeting the working capital requirements associated with manufacturing the Proposed Products. Additionally, the working capital needs for the company’s ongoing business operations will be addressed, ensuring smooth day-to-day functioning.

Debt Repayment: The company plans to use a part of the Net Proceeds for the prepayment or repayment of certain outstanding borrowings. This strategic move aims to enhance financial flexibility and optimize the company’s capital structure.

General Corporate Purposes: A portion of the funds will be earmarked for general corporate purposes, providing Maxposure with flexibility to seize emerging opportunities, respond to market dynamics, and contribute to sustained growth.

These defined objectives reflect Maxposure’s commitment to leveraging the IPO proceeds for strategic initiatives that align with its business vision and industry standing. As investors evaluate the IPO, understanding these earmarked objectives provides clarity on the company’s focus areas and its drive for continued innovation and financial prudence.